SCHEMBL3469982

SCHEMBL3469982

COc1ccc(-c2cccc(C#N)c2)n2nc(C3(C(N)=O)CC3)nc12

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL509668 0.91 PDE4D (1.00) PDE4D
SCHEMBL508899 0.89 PDE4D (0.67) PDE4D
SCHEMBL508978 0.89 PDE4D (0.79) PDE4D
SCHEMBL7926842 0.87 PDE4D (0.79) PDE4D
SCHEMBL508986 0.87 PDE4D (0.83) PDE4D
SCHEMBL508880 0.87 PDE4D (0.79) PDE4D
SCHEMBL17554728 0.87 PDE4D (0.77) PDE4D
SCHEMBL508989 0.87 PDE4D (0.80) PDE4D
SCHEMBL509085 0.86 PDE4D (0.76) PDE4D
SCHEMBL509944 0.85 PDE4D (0.75) PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379548-B1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA AS (DK) 2016-03-09 EP claimed
US-8952162-B2 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases LEO PHARMA A/S (DK) 2015-02-10 US claimed
EP-2379548-B1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA AS (DK) 2016-03-09 EP disclosed
US-8952162-B2 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases LEO PHARMA A/S (DK) 2015-02-10 US disclosed
WO-2010069322-A1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES LEO PHARMA A/S (DK) 2010-06-24 WO disclosed